G.Barekat Pharm (XTEH:BRKT1) Price-to-Free-Cash-Flow : (As of May. 16, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Price-to-Free-Cash-Flow?

As of today (2024-05-16), G.Barekat Pharm's share price is IRR13680.00. G.Barekat Pharm does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2017. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for G.Barekat Pharm's Price-to-Free-Cash-Flow or its related term are showing as below:

XTEH:BRKT1's Price-to-Free-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 31.84
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

G.Barekat Pharm's Free Cash Flow per Share for the six months ended in Mar. 2017 was IRR-717.01.

G.Barekat Pharm Price-to-Free-Cash-Flow Historical Data

The historical data trend for G.Barekat Pharm's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Price-to-Free-Cash-Flow Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Price-to-Free-Cash-Flow

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Price-to-Free-Cash-Flow	-	-

Competitive Comparison of G.Barekat Pharm's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, G.Barekat Pharm's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Price-to-Free-Cash-Flow falls into.

G.Barekat Pharm Price-to-Free-Cash-Flow Calculation

G.Barekat Pharm's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	13680.00	/
	=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

G.Barekat Pharm (XTEH:BRKT1) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

G.Barekat Pharm Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines